Subcutaneous apomorphine in Parkinson's disease

Apomorphine remains largely underused in the treatment of Parkinson's disease. However, it has an antagonistic effect on side effects of levodopa such as dyskinesias and nausea.

Saved in:
Bibliographic Details
Published in:BMJ 1998-02, Vol.316 (7132), p.641-641
Main Authors: Chaudhuri, K Ray, Clough, C
Format: Article
Language:English
Subjects:
Administration, Cutaneous
Antiparkinson Agents - administration & dosage
Apomorphine - administration & dosage
Drug therapy
Drugs
Editorials
Humans
Parkinson Disease - drug therapy
Parkinson's disease
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Apomorphine remains largely underused in the treatment of Parkinson's disease. However, it has an antagonistic effect on side effects of levodopa such as dyskinesias and nausea.
ISSN:0959-8138
0959-8146
1468-5833
DOI:10.1136/bmj.316.7132.641